Loading company…
Megakaryon Corporation, based in Kyoto, Japan, develops human platelet products made from induced pluripotent stem cells.
Founded in 2011 and based in Kyoto, Japan, Megakaryon Corporation produces human platelet products derived from induced pluripotent stem cells. Its MEG-002 product is linked to the Nakauchi-Eto patent. On December 21, 2023, the company raised JPY 2,800 mn in a Series D round from investors including INCJ and SBI Investment, at a current valuation of JPY 18,672.059 mn. The company has completed five deals to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in